Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-17
1996-02-20
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514319, 514322, 514324, 514326, 514362, 514363, 514365, 514372, 514394, 514396, 514414, 544335, 546193, 546199, 546201, 546202, 546205, 546209, 546210, 548127, 548128, 548205, 548214, 548253, 5483061, 548467, 548468, A61K 31445, C07D40106, C07D20904
Patent
active
054929202
ABSTRACT:
The present invention is directed to certain novel compounds identified as substituted piperidines, pyrrolidines and hexahydro-1H-azepines of the general structural formula: ##STR1## wherein R.sub.1, R.sub.4, R.sub.5, A, X, Y and n are as defined herein. These compounds promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such compounds as the active ingredient thereof are also disclosed.
REFERENCES:
patent: 3239345 (1966-03-01), Hodge et al.
patent: 4036979 (1977-07-01), Asato
patent: 4411890 (1983-10-01), Momany
patent: 4782139 (1988-11-01), DiMarchi
patent: 5137872 (1992-08-01), Seely et al.
patent: 5164368 (1992-04-01), Recker
patent: 5206235 (1993-04-01), Fisher et al.
patent: 5283241 (1994-02-01), Bochis et al.
patent: 5284841 (1994-02-01), Chu et al.
patent: 5310737 (1994-05-01), Fisher et al.
patent: 5317017 (1994-05-01), Ok et al.
R. G. Smith, et al., Science, Reprint Series, 11 Jun. 1993, vol. 260, pp. 1640-1643 "A Nonpeptidyl Growth Hormone Secretagogue".
Ammann et al. "IGF--I and painidronate increase bone mineral density in ovariectomized adult rats" Am. J. Physiology 265 pE 770-6 (1993).
Sakamoto, et al., Chem. Abstracts, 113 (9) 73,560u (1990).
Horwell, et al., Chem. Abstracts, 113 (15) 132,771p (1990).
Chen Meng H.
Nargund Ravi
Patchett Arthur A.
Yang Lihu
Chang Ceila
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Piperidine, pyrrolidine and hexahydro-1H-azepines promote releas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine, pyrrolidine and hexahydro-1H-azepines promote releas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine, pyrrolidine and hexahydro-1H-azepines promote releas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1356077